With FDA Approval Of Pfizer Vaccine Imminent, Universities Are Ramping Up The Mandates - Forbes | Canada News Media
Connect with us

Health

With FDA Approval Of Pfizer Vaccine Imminent, Universities Are Ramping Up The Mandates – Forbes

Published

 on


With multiple news outlets reporting that the U.S. Food and Drug Administration (FDA) is expected to approve Pfizer-BioNTech’s two-dose Covid-19 vaccine this week – perhaps as early as Monday – several universities are announcing they will implement vaccination mandates for their students, faculty and staff as soon as the approval is finalized.

Others have indicted that once FDA approval is in place for at least one vaccine, they will revisit their current policies, possibly implementing mandates they’ve resisted up until now. (Moderna’s application for full approval for its vaccine is still under review, but a decision on it also could be handed down in a few weeks.)

The absence of formal FDA approval for a Covid-19 vaccine has been a stumbling block for some campus leaders for at least two reasons. First, they’ve feared that without such approval vaccine-hesitant individuals or state officials might have a better chance at successful legal challenges to a campus vaccine requirement. And second, they’ve not wanted to antagonize those campus constituents who have expressed concerns about having to receive a vaccine that was officially authorized for emergency use only.

Among the universities recently announcing that a vaccine mandate will be put in place after formal FDA approval is granted is the University of Memphis, whose president, M. David Rudd, was quoted in the Memphis Commercial Appeal as saying, “Once the CDC provides full authorization, as is the case for the other vaccines, we will absolutely pursue (mandating COVID vaccines). My guess is once (full approval) occurs, it will be more difficult at the legislative level to disallow mandatory vaccinations simply because we have mandatory vaccinations in a number of areas.”

Rudd added, “If in fact the vaccine is authorized within the coming week, we will be pursuing the issue, in coordination with the state immediately.”

In Louisiana, which has seen a particularly deadly surge of the coronavirus in recent weeks, both Governor John Bel Edwards and university leaders indicated they would impose vaccination requirements as soon as the FDA took final action.

Louisiana State University President William Tate said that LSU would move “swiftly” to mandate Covid-19 vaccinations following full FDA authorization. Administrators at other institutions in the state – including the University of Louisiana – Lafayette – have issued similar statements. Last week, UL – Lafayette updated its Covid-19 protocol with the following:

“We expect the Food and Drug Administration to approve one or more COVID-19 vaccines soon. Once this happens, the University of Louisiana System will require all students be vaccinated. The University strongly encourages students to get vaccinated now in anticipation of the FDA’s approval.”

Among other universities that have premised or strengthened their mandates contingent on the anticipated FDA approval of the Pfizer vaccine are the University of Minnesota and Washington State University.

Pressure on university leaders for mandated vaccinations is mounting from several directions. Faculty are growing increasingly impatient with administrators who will not impose such requirements. Students are making the case for vaccinations with their peers.

And public health officials are calling for more mandates after the FDA acts. For example, Dr. Anthony Fauci recently told USA TODAY’s Editorial Board “Organizations, enterprises, universities, colleges that have been reluctant to mandate at the local level will feel much more confident. They can say: ‘If you want to come to this college or this university, you’ve got to get vaccinated. If you want to work in this plant, you have to get vaccinated. If you want to work in this enterprise, you’ve got to get vaccinated. If you want to work in this hospital, you’ve got to get vaccinated.'”

Also last week, the COVID Collaborative, a group of more than three dozen public health and science experts, officials from both political parties, and higher education leaders wrote a letter to college administrators asking them “to join us in taking further steps to maintain public health and safety, prevent spread, and keep your institutions open for student learning. We are asking you to require vaccination. A vaccination requirement is the best way to protect students, faculty, staff and the community around your campus.”

More than 700 American colleges and universities have now imposed a vaccine requirement. With the Delta variant of the virus still wreaking deadly havoc across the nation, threatening more disruptions to campus operations just as the fall semester begins, look for that number to grow substantially when the first vaccine moves from emergency use authorization to its much- anticipated full FDA approval.

Adblock test (Why?)



Source link

Continue Reading

Health

Canada to donate up to 200,000 vaccine doses to combat mpox outbreaks in Africa

Published

 on

 

The Canadian government says it will donate up to 200,000 vaccine doses to fight the mpox outbreak in Congo and other African countries.

It says the donated doses of Imvamune will come from Canada’s existing supply and will not affect the country’s preparedness for mpox cases in this country.

Minister of Health Mark Holland says the donation “will help to protect those in the most affected regions of Africa and will help prevent further spread of the virus.”

Dr. Madhukar Pai, Canada research chair in epidemiology and global health, says although the donation is welcome, it is a very small portion of the estimated 10 million vaccine doses needed to control the outbreak.

Vaccine donations from wealthier countries have only recently started arriving in Africa, almost a month after the World Health Organization declared the mpox outbreak a public health emergency of international concern.

A few days after the declaration in August, Global Affairs Canada announced a contribution of $1 million for mpox surveillance, diagnostic tools, research and community awareness in Africa.

On Thursday, the Africa Centres for Disease Control and Prevention said mpox is still on the rise and that testing rates are “insufficient” across the continent.

Jason Kindrachuk, Canada research chair in emerging viruses at the University of Manitoba, said donating vaccines, in addition to supporting surveillance and diagnostic tests, is “massively important.”

But Kindrachuk, who has worked on the ground in Congo during the epidemic, also said that the international response to the mpox outbreak is “better late than never (but) better never late.”

“It would have been fantastic for us globally to not be in this position by having provided doses a much, much longer time prior than when we are,” he said, noting that the outbreak of clade I mpox in Congo started in early 2023.

Clade II mpox, endemic in regions of West Africa, came to the world’s attention even earlier — in 2022 — as that strain of virus spread to other countries, including Canada.

Two doses are recommended for mpox vaccination, so the donation may only benefit 100,000 people, Pai said.

Pai questioned whether Canada is contributing enough, as the federal government hasn’t said what percentage of its mpox vaccine stockpile it is donating.

“Small donations are simply not going to help end this crisis. We need to show greater solidarity and support,” he said in an email.

“That is the biggest lesson from the COVID-19 pandemic — our collective safety is tied with that of other nations.”

This report by The Canadian Press was first published Sept. 13, 2024.

Canadian Press health coverage receives support through a partnership with the Canadian Medical Association. CP is solely responsible for this content.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Health

How many Nova Scotians are on the doctor wait-list? Number hit 160,000 in June

Published

 on

 

HALIFAX – The Nova Scotia government says it could be months before it reveals how many people are on the wait-list for a family doctor.

The head of the province’s health authority told reporters Wednesday that the government won’t release updated data until the 160,000 people who were on the wait-list in June are contacted to verify whether they still need primary care.

Karen Oldfield said Nova Scotia Health is working on validating the primary care wait-list data before posting new numbers, and that work may take a matter of months. The most recent public wait-list figures are from June 1, when 160,234 people, or about 16 per cent of the population, were on it.

“It’s going to take time to make 160,000 calls,” Oldfield said. “We are not talking weeks, we are talking months.”

The interim CEO and president of Nova Scotia Health said people on the list are being asked where they live, whether they still need a family doctor, and to give an update on their health.

A spokesperson with the province’s Health Department says the government and its health authority are “working hard” to turn the wait-list registry into a useful tool, adding that the data will be shared once it is validated.

Nova Scotia’s NDP are calling on Premier Tim Houston to immediately release statistics on how many people are looking for a family doctor. On Tuesday, the NDP introduced a bill that would require the health minister to make the number public every month.

“It is unacceptable for the list to be more than three months out of date,” NDP Leader Claudia Chender said Tuesday.

Chender said releasing this data regularly is vital so Nova Scotians can track the government’s progress on its main 2021 campaign promise: fixing health care.

The number of people in need of a family doctor has more than doubled between the 2021 summer election campaign and June 2024. Since September 2021 about 300 doctors have been added to the provincial health system, the Health Department said.

“We’ll know if Tim Houston is keeping his 2021 election promise to fix health care when Nova Scotians are attached to primary care,” Chender said.

This report by The Canadian Press was first published Sept. 11, 2024.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Health

Newfoundland and Labrador monitoring rise in whooping cough cases: medical officer

Published

 on

 

ST. JOHN’S, N.L. – Newfoundland and Labrador‘s chief medical officer is monitoring the rise of whooping cough infections across the province as cases of the highly contagious disease continue to grow across Canada.

Dr. Janice Fitzgerald says that so far this year, the province has recorded 230 confirmed cases of the vaccine-preventable respiratory tract infection, also known as pertussis.

Late last month, Quebec reported more than 11,000 cases during the same time period, while Ontario counted 470 cases, well above the five-year average of 98. In Quebec, the majority of patients are between the ages of 10 and 14.

Meanwhile, New Brunswick has declared a whooping cough outbreak across the province. A total of 141 cases were reported by last month, exceeding the five-year average of 34.

The disease can lead to severe complications among vulnerable populations including infants, who are at the highest risk of suffering from complications like pneumonia and seizures. Symptoms may start with a runny nose, mild fever and cough, then progress to severe coughing accompanied by a distinctive “whooping” sound during inhalation.

“The public, especially pregnant people and those in close contact with infants, are encouraged to be aware of symptoms related to pertussis and to ensure vaccinations are up to date,” Newfoundland and Labrador’s Health Department said in a statement.

Whooping cough can be treated with antibiotics, but vaccination is the most effective way to control the spread of the disease. As a result, the province has expanded immunization efforts this school year. While booster doses are already offered in Grade 9, the vaccine is now being offered to Grade 8 students as well.

Public health officials say whooping cough is a cyclical disease that increases every two to five or six years.

Meanwhile, New Brunswick’s acting chief medical officer of health expects the current case count to get worse before tapering off.

A rise in whooping cough cases has also been reported in the United States and elsewhere. The Pan American Health Organization issued an alert in July encouraging countries to ramp up their surveillance and vaccination coverage.

This report by The Canadian Press was first published Sept. 10, 2024.

The Canadian Press. All rights reserved.

Source link

Continue Reading

Trending

Exit mobile version